간·담낭·소화기
4 분 소요
EASL‑EASD‑EASO Guidance: resmetirom and semaglutide Recommended Use in MASH
This summary compiles the 2026 joint guidance, describing when to consider resmetirom or s…
전체 글
신장병과 함께 살아가는 모든 면을 탐색합니다
간·담낭·소화기
4 분 소요
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Risk of Atrial Fibrillation Recurrence After Catheter Ablation: Systematic Review and Met
A systematic review and random-effects meta-analysis showed MASLD and higher liver fibrosi…
간·담낭·소화기
11 분 소요
Fatty Liver Is More Than "Fat in the Liver": The MASLD Rename, How to Calculate FIB-4, Who Needs Fibrosis Testing, and How Much Weight Loss Works
About 1 in 3 adults worldwide has fatty liver; in Taiwan and Japan prevalence is around 30…
근거 검증
9 분 소요
查核：「脂肪肝沒什麼大不了，反正也沒藥醫」是真的嗎？
兩句都不對。脂肪肝（現稱 MASLD）影響全球約 30% 成人，少數會進展到肝纖維化、肝硬化與肝癌，也是心血管疾病與慢性腎臟病的獨立危險因子…
